Glycogen synthase kinase-3 regulates microglial migration, inflammation, and inflammation-induced neurotoxicity

Christopher J. Yuskaitis, Richard S Jope

Research output: Contribution to journalArticle

135 Citations (Scopus)

Abstract

Microglia play a prominent role in the brain's inflammatory response to injury or infection by migrating to affected locations, secreting inflammatory molecules, and phagocytosing damaged tissue. However, because severe or chronic neuroinflammation exacerbates many neurological conditions, controlling microglia actions may provide therapeutic benefits in a diverse array of diseases. Since glycogen synthase kinase-3 (GSK3) promotes inflammatory responses in peripheral immune cells, we investigated if inhibitors of GSK3 attenuated microglia responses to inflammatory stimuli. Treatment of BV-2 microglia with GSK3 inhibitors greatly reduced the migration of microglia in both a scratch assay and in a transwell migration assay. Treatment of BV-2 microglia with lipopolysaccharide (LPS) stimulated the production of interleukin-6 and increased the expression of inducible nitric oxide synthase (iNOS) and NO production. Each of these microglia responses to inflammatory stimulation were greatly attenuated by GSK3 inhibitors. However, GSK3 inhibitors did not cause a general impairment of microglia functions, as the LPS-induced stimulated expression of cylcooxygenase-2 was unaltered. Regulation of microglia functions were also evident in cultured mouse hippocampal slices where GSK3 inhibitors reduced cytokine production and microglial migration, and provided protection from inflammation-induced neuronal toxicity. These findings demonstrate that GSK3 promotes microglial responses to inflammation and that the utilization of GSK3 inhibitors provides a means to limit the inflammatory actions of microglia.

Original languageEnglish
Pages (from-to)264-273
Number of pages10
JournalCellular Signalling
Volume21
Issue number2
DOIs
StatePublished - Feb 1 2009
Externally publishedYes

Fingerprint

Glycogen Synthase Kinase 3
Microglia
Inflammation
Lipopolysaccharides
Nitric Oxide Synthase Type II
Phagocytosis
Interleukin-6
Cytokines

Keywords

  • Cytokine
  • GSK3
  • Lipopolysaccharide
  • Lithium
  • Microglia motility
  • Neuroinflammation
  • Neuroprotection

ASJC Scopus subject areas

  • Cell Biology

Cite this

Glycogen synthase kinase-3 regulates microglial migration, inflammation, and inflammation-induced neurotoxicity. / Yuskaitis, Christopher J.; Jope, Richard S.

In: Cellular Signalling, Vol. 21, No. 2, 01.02.2009, p. 264-273.

Research output: Contribution to journalArticle

@article{f02999b0c4af4de9a3ca51ec0ffc683e,
title = "Glycogen synthase kinase-3 regulates microglial migration, inflammation, and inflammation-induced neurotoxicity",
abstract = "Microglia play a prominent role in the brain's inflammatory response to injury or infection by migrating to affected locations, secreting inflammatory molecules, and phagocytosing damaged tissue. However, because severe or chronic neuroinflammation exacerbates many neurological conditions, controlling microglia actions may provide therapeutic benefits in a diverse array of diseases. Since glycogen synthase kinase-3 (GSK3) promotes inflammatory responses in peripheral immune cells, we investigated if inhibitors of GSK3 attenuated microglia responses to inflammatory stimuli. Treatment of BV-2 microglia with GSK3 inhibitors greatly reduced the migration of microglia in both a scratch assay and in a transwell migration assay. Treatment of BV-2 microglia with lipopolysaccharide (LPS) stimulated the production of interleukin-6 and increased the expression of inducible nitric oxide synthase (iNOS) and NO production. Each of these microglia responses to inflammatory stimulation were greatly attenuated by GSK3 inhibitors. However, GSK3 inhibitors did not cause a general impairment of microglia functions, as the LPS-induced stimulated expression of cylcooxygenase-2 was unaltered. Regulation of microglia functions were also evident in cultured mouse hippocampal slices where GSK3 inhibitors reduced cytokine production and microglial migration, and provided protection from inflammation-induced neuronal toxicity. These findings demonstrate that GSK3 promotes microglial responses to inflammation and that the utilization of GSK3 inhibitors provides a means to limit the inflammatory actions of microglia.",
keywords = "Cytokine, GSK3, Lipopolysaccharide, Lithium, Microglia motility, Neuroinflammation, Neuroprotection",
author = "Yuskaitis, {Christopher J.} and Jope, {Richard S}",
year = "2009",
month = "2",
day = "1",
doi = "10.1016/j.cellsig.2008.10.014",
language = "English",
volume = "21",
pages = "264--273",
journal = "Cellular Signalling",
issn = "0898-6568",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Glycogen synthase kinase-3 regulates microglial migration, inflammation, and inflammation-induced neurotoxicity

AU - Yuskaitis, Christopher J.

AU - Jope, Richard S

PY - 2009/2/1

Y1 - 2009/2/1

N2 - Microglia play a prominent role in the brain's inflammatory response to injury or infection by migrating to affected locations, secreting inflammatory molecules, and phagocytosing damaged tissue. However, because severe or chronic neuroinflammation exacerbates many neurological conditions, controlling microglia actions may provide therapeutic benefits in a diverse array of diseases. Since glycogen synthase kinase-3 (GSK3) promotes inflammatory responses in peripheral immune cells, we investigated if inhibitors of GSK3 attenuated microglia responses to inflammatory stimuli. Treatment of BV-2 microglia with GSK3 inhibitors greatly reduced the migration of microglia in both a scratch assay and in a transwell migration assay. Treatment of BV-2 microglia with lipopolysaccharide (LPS) stimulated the production of interleukin-6 and increased the expression of inducible nitric oxide synthase (iNOS) and NO production. Each of these microglia responses to inflammatory stimulation were greatly attenuated by GSK3 inhibitors. However, GSK3 inhibitors did not cause a general impairment of microglia functions, as the LPS-induced stimulated expression of cylcooxygenase-2 was unaltered. Regulation of microglia functions were also evident in cultured mouse hippocampal slices where GSK3 inhibitors reduced cytokine production and microglial migration, and provided protection from inflammation-induced neuronal toxicity. These findings demonstrate that GSK3 promotes microglial responses to inflammation and that the utilization of GSK3 inhibitors provides a means to limit the inflammatory actions of microglia.

AB - Microglia play a prominent role in the brain's inflammatory response to injury or infection by migrating to affected locations, secreting inflammatory molecules, and phagocytosing damaged tissue. However, because severe or chronic neuroinflammation exacerbates many neurological conditions, controlling microglia actions may provide therapeutic benefits in a diverse array of diseases. Since glycogen synthase kinase-3 (GSK3) promotes inflammatory responses in peripheral immune cells, we investigated if inhibitors of GSK3 attenuated microglia responses to inflammatory stimuli. Treatment of BV-2 microglia with GSK3 inhibitors greatly reduced the migration of microglia in both a scratch assay and in a transwell migration assay. Treatment of BV-2 microglia with lipopolysaccharide (LPS) stimulated the production of interleukin-6 and increased the expression of inducible nitric oxide synthase (iNOS) and NO production. Each of these microglia responses to inflammatory stimulation were greatly attenuated by GSK3 inhibitors. However, GSK3 inhibitors did not cause a general impairment of microglia functions, as the LPS-induced stimulated expression of cylcooxygenase-2 was unaltered. Regulation of microglia functions were also evident in cultured mouse hippocampal slices where GSK3 inhibitors reduced cytokine production and microglial migration, and provided protection from inflammation-induced neuronal toxicity. These findings demonstrate that GSK3 promotes microglial responses to inflammation and that the utilization of GSK3 inhibitors provides a means to limit the inflammatory actions of microglia.

KW - Cytokine

KW - GSK3

KW - Lipopolysaccharide

KW - Lithium

KW - Microglia motility

KW - Neuroinflammation

KW - Neuroprotection

UR - http://www.scopus.com/inward/record.url?scp=57749173844&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=57749173844&partnerID=8YFLogxK

U2 - 10.1016/j.cellsig.2008.10.014

DO - 10.1016/j.cellsig.2008.10.014

M3 - Article

VL - 21

SP - 264

EP - 273

JO - Cellular Signalling

JF - Cellular Signalling

SN - 0898-6568

IS - 2

ER -